LLY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eli Lilly and Co

Watchlist Manager

Watchlist

Price: 1 036.6 EUR -1.56% Market Closed

Market Cap: €985.2B

E	Eli Lilly and Co F:LLY	US
R	RWE AG XMUN:RWE	DE
	Taskus Inc NASDAQ:TASK	US
A	Anglo American Platinum Ltd XMUN:RPHA	ZA
	Freshworks Inc F:7DF	US
	Tuya Inc F:7850	CN
	Virgin Galactic Holdings Inc F:0QL	US
T	Takeda Pharmaceutical Co Ltd XMUN:TKD	JP
	Washington H Soul Pattinson and Company Ltd ASX:SOL	AU
C	Companhia Energetica de Minas Gerais CEMIG F:CID	BR
N	Niterra Co Ltd XMUN:NGK	JP
H	Helix Energy Solutions Group Inc F:CTV	US
R	RPC Inc F:RLD	US
H	Hewlett Packard Enterprise Co F:2HP	US

Profitability Summary

Eli Lilly and Co's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

81%

Gross Margin is Increasing

78% > 83%

Exceptional Operating Margin

47%

Strong 3Y Average Operating Margin

37%

Operating Margin is Increasing

27% > 47%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

22% > 35%

Exceptional Free Cash Flow Margin

14%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

11% > 14%

Exceptional ROE

108%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

21%

ROIC is Increasing

15% > 29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.